Ponad 7000 publikacji medycznych!
Statystyki za 2021 rok:
odsłony: 8 805 378
Artykuły w Czytelni Medycznej o SARS-CoV-2/Covid-19

Poniżej zamieściliśmy fragment artykułu. Informacja nt. dostępu do pełnej treści artykułu tutaj
© Borgis - New Medicine 3/2011, s. 84-89
*Agata Kabała-Dzik1, Anna Rzepecka-Stojko2, Jerzy Stojko3, Ewa Szaflarska-Stojko1, Magdalena Wyszyńska1, Robert Kubina1, Aleksandra Kolarczyk1, Wojciech Marquardt1, Barbara Stawiarska-Pięta1
Evaluation Attempt of Bee Larva DNA Influence on the Course of Rat Pregnancy
1Department and Institute of Pathology, The Faculty of Pharmacy in Sosnowiec, Medical University of Silesia
Head of Department: dr hab. n. med. Barbara Stawiarska-Pięta
2Department of Pharmaceutical Chemistry, The Faculty of Pharmacy in Sosnowiec, Medical University of Silesia
Head of Department: prof. dr hab. n. farm. Ewa Buszman 3Department of Hygiene, Bioanalysis and Environmental Studies, The Faculty of Pharmacy in Sosnowiec, Medical University of Silesia
Head of Department: dr hab. n. med. Jerzy Stojko
Introduction. Beneficial properties of products collected, processed and secreted by bees, have been known and used for centuries. The latest trend in apitherapy is examination of a possibility to apply bee larva extract in proteinotherapy. The key to success and at the same time the greatest difficulty in experiments regarding a therapy with DNA application, is the use of an appropriate carrier, called vector. The simplest way of genetic material transport is a direct injection into target, uncovered tissues or organs, bare DNA molecules, suspended in a buffer solution.
The aim of the study. The aim of the study was evaluation of bee larva DNA influence upon the course of rat pregnancy, following the administration by intraperitoneal injection. Control group I included 10 rat females, which were administered sodium chloride solution by intraperitoneal injection on day 4, 10 and 14 of pregnancy. Experimental group I included 10 females, which were administered bee larva DNA biopreparation by intraperitoneal route in 50 μg on day 4, 10, 14 of pregnancy.
Material and methods. After the elimination of both animal groups on 21st day of pregnancy, zootomic examinations of mothers and fetuses were performed, including: macroscopic inspection of females′ internal organs, evaluation of culture parameters of females, external inspection of rat fetuses and morphometric measurements of their bodies and evaluation of the number of ossification points in fetuses.
Results and conclusions. The analysis of the results obtained in both examined groups indicates, that bee larva DNA does not cause pathologic changes within internal organs of pregnant female rats, does not cause defects in fetuses′ development and also does not contribute to the occurrence of congenital defects in fetuses.
Key words: bee larva, DNA, rat fetus.
In recent years there has been a renaissance of natural medicine, a large interest in pharmacopeial items, hence, apitherapy appears as a major alternative for a variety of synthetic therapeutics.
The latest studies confirm cytoprotective action of apipharmacotherapeutics in the course of anticancer treatment. In the studies concerning hepatic tissue and crosswise-striped cardiac tissue in rats, a protective action of propolis extracts was shown in relation to these tissues, manifested in the reduction of defects resulting from oxidative stress (1-8).
In recent time, scientists have been interested in the possibility of introducing a new raw material into apitherapy, which is bee larva. Although gene therapy appears to be a promising perspective in the treatment of various ailments, some limitations impede its wide application. These matters are mainly connected with a lack of a universal carrier, with a possibility of a strong immunologic response induction by means of nucleic acids administered into the body, or achieving an appropriately long-term therapeutic action. The key to success, and at the same time the greatest difficulty in experiments concerned with gene therapy is the use of an appropriate carrier i.e., vector. One of the methods is injecting bare, uncovered DNA molecules, suspended in a buffer solution into pathologically altered tissues or organs (9-15). Developing fetus is extremely sensitive to destructive action of toxic substances, due to the lack of its own biotransformation systems, and therefore, totally dependent on the mother and exposed to all substances in her body, capable of crossing placental barrier. Due to this fact, intraperitoneal administration of bee larva DNA extract to protect the fetus against environmental toxins must be preceded by an accurate analysis of the effect of this substance upon mother′s body and developing fetus, along with confirmation and documentation of its efficacy and safety in use.
The aim of the study was evaluation of bee larva DNA influence on the course of pregnancy in female rat after administration of this substance by intraperitoneal route. It was achieved by answering the following questions:
– What are the effects of bee larva DNA upon pregnant female rats?
– Has bee larva DNA any influence on morphometric parameters of rat fetuses?
– How does bee larva DNA affect osteoarticular system of a fetus?
In the experiment were used 20 pregnant female Wistar rats, approximately 3 months old, with body mass 170 ± 20 g, from the Experimental Medicine Culture Centre of the Medical University of Silesia. The experiment was approved by Ethics Commission (agreement no.: 34/4, 9th of November 2004). The research was financed by Medical University of Silesia (no, KNW-2-015/09).
Rats were divided into 2 groups of 10 animals: control group C – the female rats which were administered physiological saline in a form of intraperitoneal injection, on day 4, 10 and 14 of pregnancy.
Experimental group I – the female rats, which were administered bee larva DNA extract of 50 μg as a suspension in physiological saline (1 ml) in a form of intraperitoneal injection on day 4, 10 and 14 of pregnancy.
Bee larva DNA biopreparation was made for experimental purposes at the department and Faculty of Molecular Biology of Medical University of Silesia in Katowice, in accordance with the standard DNA isolation procedure (15).
On 21st day of pregnancy the rats were anesthetized by intraperitoned administration of morbital at a dose of 200 mg/kg body weight and the following examinations were performed, including:
– Zootomic examination of rat mother, upon which macroscopic inspection of particular organs was made and the following were determined:
• number of fetuses in each of uterus horns;
• number of visible focci of fetuses resorption;
• number of corpuses luteum (yellow bodies) in each ovary;
– morphometric measurements of fetus body:
• weighing a fetus along with placenta;
• weighing a fetus without placenta;
• measurement of a fetus length from mouth to tail base;
• measurement of a fetus length from mouth to tail′s end;
• inspection of all fetuses in order to identify possible congenital defects;
• exposing all ossification points of fetuses by means of Mocca-Dowson′s method;
• counting ossification points in metacarpus, metatarsus and sternum of fetuses.
Statistical analysis

Powyżej zamieściliśmy fragment artykułu, do którego możesz uzyskać pełny dostęp.
Mam kod dostępu
  • Aby uzyskać płatny dostęp do pełnej treści powyższego artykułu albo wszystkich artykułów (w zależności od wybranej opcji), należy wprowadzić kod.
  • Wprowadzając kod, akceptują Państwo treść Regulaminu oraz potwierdzają zapoznanie się z nim.
  • Aby kupić kod proszę skorzystać z jednej z poniższych opcji.

Opcja #1


  • dostęp do tego artykułu
  • dostęp na 7 dni

uzyskany kod musi być wprowadzony na stronie artykułu, do którego został wykupiony

Opcja #2


  • dostęp do tego i pozostałych ponad 7000 artykułów
  • dostęp na 30 dni
  • najpopularniejsza opcja

Opcja #3


  • dostęp do tego i pozostałych ponad 7000 artykułów
  • dostęp na 90 dni
  • oszczędzasz 28 zł
1. Stojko A: Czerw pszczeli nowym surowcem farmakopealnym. Materiały z Naukowej Konferencji Pszczelarskiej, Puławy 2005, http://www.opisik.pulawy.pl/pdf/matXLII.pdf, www.opisik.pulawy.pl. 2. Benguedouar L, Boussenane HN, Wided K et al.: Efficiency of propolis extract against mitochondrial stress induced by antineoplasic agents (doxorubicin and vinblastin) in rats. Indian J Exp Biol 2008; 2: 112-9. 3. Temiz M, Aslan A, Canbolant E et al.: Effect of propolis on healing in experimental colon anastomosis in rats. Adv Ther 2008; 28: 412-21. 4. Couteau C, Pommier M, Paparis E et al.: Photoprotective activity of propolis. Nat Prod Res 2008; 22: 264-8. 5. Inokuchi I, Shimazawa M, Nakajima Y et al.: Brazilian Green Propolis protects against Retinal Damage in vitro and in vivo. Evid-Based Compl Alt Med 2006; 3: 71-7. 6. Weinstock GM, Robinson GE, Gibbs RA et al.: Insights into social insects from the genome of the honeybee Apis mellifera. Nature 2006; 443(7114): 931-49. 7. Kabała-Dzik A, Szaflarska-Stojko E, Wojtyczka R et al.: Efficiency assessment of antimicrobial activity of honey-balm on experimental burn wounds. Bul Vet Inst Pulawy 2004; 48: 109-12. 8. Evans JD, Aronstein K, Chen YP et al.: Immune pathways and defence mechanisms in honey bees Apis mellifera. Insect Mol Biol 2006; 15: 645-56. 9. Anson DS: The use of retroviral vectors for gene therapy – what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery. Gene Vac Ther 2004; 2: 9-15. 10. Relph K, Harrington K, Pandha H: Recent developments and current status of gene therapy using viral vectors in the United Kingdom. Br Med J 2004; 329: 839-42. 11. Glasgow JN, Everts M, Curiel DT: Transductional targeting of adenovirus vectors for gene therapy. Cancer Gene Ther 2006; 13: 830-844. 12. Coura dos Santos R, Beyer Nardi N: The state of the art of adeno-associated virus-based vectors in gene therapy. Vir J 2007; 4: 99. 13. Goverdhana S, Puntel M, Xiong W et al.: Regulatable Gene Expression Systems for Gene Therapy Applications: Progress and Future Challenges. Curr Gene Ther 2006; 6: 421-38. 14. Helenius E, Boije M, Niklander-Teeri V et al.: Gene delivery into intact plants using the Helios Gene Gun. Plant Mol Biol Reptr 2000; 18: 287a-287l. 15. Barki Y, Douek J, Graur D et al.: Polymorphism in soft coral larvae revealed by amplified fragment-lenght polymorphism (AFLP) markers. Mar Biol 2000; 136: 37-41.
otrzymano: 2011-08-30
zaakceptowano do druku: 2011-09-12

Adres do korespondencji:
*Agata Kabała-Dzik
Katedra i Zakład Patologii, Wydział Farmaceutczny z Oddziałem Medycyny Laboratoryjnej
Śląski Uniwersytet Medyczny
ul. Ostrogórska 30, 41-200 Sosnowiec
email: adzik@sum.edu.pl

New Medicine 3/2011
Strona internetowa czasopisma New Medicine